GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $680,000 | +12.8% | 15,605 | +12.8% | 0.01% | +25.0% |
| Q1 2022 | $603,000 | +5.2% | 13,834 | +6.6% | 0.01% | -11.1% |
| Q4 2021 | $573,000 | +13.7% | 12,973 | -1.7% | 0.01% | +50.0% |
| Q3 2021 | $504,000 | -16.0% | 13,194 | -12.5% | 0.01% | -25.0% |
| Q2 2021 | $600,000 | -17.1% | 15,079 | -25.8% | 0.01% | -20.0% |
| Q1 2021 | $724,000 | +10.0% | 20,311 | +13.6% | 0.01% | 0.0% |
| Q4 2020 | $658,000 | +8.2% | 17,876 | +10.6% | 0.01% | 0.0% |
| Q3 2020 | $608,000 | -11.6% | 16,162 | -4.1% | 0.01% | -23.1% |
| Q2 2020 | $688,000 | +34.9% | 16,859 | +25.3% | 0.01% | +8.3% |
| Q1 2020 | $510,000 | -16.4% | 13,458 | +3.6% | 0.01% | +9.1% |
| Q4 2019 | $610,000 | +55.6% | 12,991 | +41.5% | 0.01% | +37.5% |
| Q3 2019 | $392,000 | -6.4% | 9,179 | -12.3% | 0.01% | -42.9% |
| Q2 2019 | $419,000 | +1.2% | 10,464 | +5.5% | 0.01% | -12.5% |
| Q1 2019 | $414,000 | +11.9% | 9,914 | +2.4% | 0.02% | 0.0% |
| Q4 2018 | $370,000 | -18.3% | 9,684 | -14.2% | 0.02% | 0.0% |
| Q3 2018 | $453,000 | -0.9% | 11,288 | -0.5% | 0.02% | -11.1% |
| Q2 2018 | $457,000 | -9.3% | 11,348 | -12.0% | 0.02% | -5.3% |
| Q1 2018 | $504,000 | -25.6% | 12,890 | -32.5% | 0.02% | -24.0% |
| Q4 2017 | $677,000 | -13.4% | 19,090 | -0.9% | 0.02% | -16.7% |
| Q3 2017 | $782,000 | -5.7% | 19,262 | +0.1% | 0.03% | -9.1% |
| Q2 2017 | $829,000 | -10.1% | 19,236 | -12.0% | 0.03% | -10.8% |
| Q1 2017 | $922,000 | -0.4% | 21,860 | -9.1% | 0.04% | -2.6% |
| Q4 2016 | $926,000 | -3.5% | 24,052 | +8.1% | 0.04% | -2.6% |
| Q3 2016 | $960,000 | -21.7% | 22,253 | -21.3% | 0.04% | -22.0% |
| Q2 2016 | $1,226,000 | +6.6% | 28,291 | -0.3% | 0.05% | +6.4% |
| Q1 2016 | $1,150,000 | -2.6% | 28,374 | -3.0% | 0.05% | 0.0% |
| Q4 2015 | $1,181,000 | -4.9% | 29,263 | -9.4% | 0.05% | -2.1% |
| Q3 2015 | $1,242,000 | -1.7% | 32,304 | +6.5% | 0.05% | +14.3% |
| Q2 2015 | $1,264,000 | -14.3% | 30,325 | -5.1% | 0.04% | -12.5% |
| Q1 2015 | $1,475,000 | +14.4% | 31,969 | +6.0% | 0.05% | +14.3% |
| Q4 2014 | $1,289,000 | – | 30,150 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |